Oncology Institute Inc (TOI)

EBITDA Growth

54.76%

Quarterly · Period ending:

TOI logo

TOI EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported54.76%
TOI Quarterly EBITDA YoY % (105.43% → 54.76%)
High-resolution chart · PNG

TOI ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Oncology Institute Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
54.7568%
108.6502%
61.5795%
-4.4336%
-13.6959%
25.4889%
25.4359%
-1.0586%
12.6236%
-11.4317%
5.5935%
-18,088.0597%
-213.3148%
-171.764%
-25.7472%
94.6528%
-189.0123%
20,427%
-181.528%
-1,364.8772%
148.0456%
105.4297%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.